Publications by authors named "Julie Locklear"

Claim this Profile
A
Assessing the Reliability and Validity of the Sheehan Irritability Scale in Patients With Major Depressive Disorder.
Sajjad A Khan, Dennis A Revicki, Mariam Hassan, Julie C Locklear, Lisa Aronson Friedman

J Clin Psychiatry· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Content validity of the Sheehan Irritability Scale in patients with major depressive disorder.
Sally Mannix, Mariam Hassan, Raj Tummala, Julie C Locklear, Dennis A Revicki

Int Clin Psychopharmacol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania.
Machaon Bonafede, Julie C Locklear, Peter Wahlqvist, Liberty Fajutrao, Johan Szamosi

J Comp Eff Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorder.
Stuart A Montgomery, Julie C Locklear, Henrik Svedsäter, Hans Eriksson

Int Clin Psychopharmacol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis.
Julie C Locklear, Peter Wahlqvist, Urban Gustafsson, Mattias Udd, Liberty Fajutrao

J Comp Eff Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate.
Anita H Clayton, Julie C Locklear, Henrik Svedsäter, Roger S McIntyre

CNS Spectr· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe.
Samira Toghanian, Marco Dibonaventura, Krister Järbrink, Julie C Locklear

Clinicoecon Outcomes Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance study.
David V Sheehan, Henrik Svedsäter, Julie C Locklear, Hans Eriksson

J Affect Disord· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.
Julie C Locklear, Berhanu Alemayehu, Robert S Brody, Soheil Chavoshi, Ozgur Tunceli

Clin Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder.
Julie C Locklear, Henrik Svedsäter, Catherine Datto, Jean Endicott

J Affect Disord· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy.
Michael E Thase, Stuart Montgomery, George I Papakostas, Michael Bauer, Madhukar H Trivedi, Julie C Locklear

Int Clin Psychopharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanistic and economic burden of generalized anxiety disorder in North America and Europe.
Dennis A Revicki, Karin Travers, Kathleen W Wyrwich, Henrik Svedsäter, Julie Locklear

J Affect Disord· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
David V Sheehan, Julie Locklear, Henrik Svedsäter, Catherine Datto

Int Clin Psychopharmacol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder.
Jean Endicott, Henrik Svedsäter, Julie C Locklear

Neuropsychiatr Dis Treat· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of quetiapine in patients with acute bipolar depression and in maintenance treatment after an acute depressive episode.
Mattias Ekman, Peter Lindgren, Carolin Miltenburger, Genevieve Meier, Julie C Locklear

Pharmacoeconomics· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder.
Kathryn Eilene Lasch, Mariam Hassan, Jean Endicott, Elisabeth Carine Piault-Luis, Julie Locklear

BMC Psychiatry· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.
Eduard Vieta, Oliver Günther, Julie Locklear, Mattias Ekman, Carolin Miltenburger

Int J Neuropsychopharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of quality of life enjoyment and satisfaction questionnaire-short form responder thresholds in generalized anxiety disorder and bipolar disorder studies.
Kathleen W Wyrwich, Neesha Harnam, Dennis A Revicki, Julie C Locklear, Henrik Svedsater

Int Clin Psychopharmacol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the relationships between health outcomes in generalized anxiety disorder clinical trials.
Kathleen W Wyrwich, Neesha Harnam, Julie C Locklear, Henrik Svedsäter, Dennis A Revicki

Qual Life Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment options for bipolar depression: a systematic review of randomized, controlled trials.
Eduard Vieta, Julie Locklear, Oliver Günther, Mattias Ekman, Carolin Miltenburger

J Clin Psychopharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing health-related quality of life in generalized anxiety disorder using the Quality Of Life Enjoyment and Satisfaction Questionnaire.
Kathleen Wyrwich, Neesha Harnam, Dennis A Revicki, Julie C Locklear, Henrik Svedsäter

Int Clin Psychopharmacol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER.
Martin Knapp, Julie Locklear, Krister Järbrink

Curr Med Res Opin· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.
Liberty Fajutrao, Björn Paulsson, Sherry Liu, Julie Locklear

Clin Ther· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia.
Krister Järbrink, Noemi Kreif, Agnes Benedict, Julie Locklear

Curr Med Res Opin· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of the evidence of the burden of bipolar disorder in Europe.
Liberty Fajutrao, Julie Locklear, Jennifer Priaulx, Anne Heyes

Clin Pract Epidemiol Ment Health· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis